(Q35591287)

9 August 2017

1 reference

title

Emerging therapeutic agents for transmissible spongiform encephalopathies: a review (English)

1 reference

9 August 2017

Koster T

1

1 reference

9 August 2017

Singh K

series ordinal

2

1 reference

9 August 2017

Zimmermann M

series ordinal

3

1 reference

9 August 2017

Gruys E

series ordinal

4

1 reference

9 August 2017

publication date

1 October 2003

1 reference

Journal of Veterinary Pharmacology and Therapeutics

9 August 2017

published in

1 reference

9 August 2017

volume

26

1 reference

9 August 2017

issue

5

1 reference

9 August 2017

page(s)

315-326

1 reference

Infected splenic dendritic cells are sufficient for prion transmission to the CNS in mouse scrapie

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

Comparison of the neuropathological characteristics of bovine spongiform encephalopathy (BSE) and variant Creutzfeldt-Jakob disease (vCJD) in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

The anti-prion activity of Congo red. Putative mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

Interactions between prion protein isoforms: the kiss of death?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

Inhibition of protease-resistant prion protein formation by porphyrins and phthalocyanines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

Pathologic conformations of prion proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

Chaperone-supervised conversion of prion protein to its protease-resistant form

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

Selective expression of prion protein in peripheral tissues of the adult mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

PrP (prion) gene expression in sheep may be modulated by alternative polyadenylation of its messenger RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

The effects of prenatal administration of azo dyes on testicular development in the mouse: a structure activity profile of dyes derived from benzidine, dimethylbenzidine, or dimethoxybenzidine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

Interactions between heterologous forms of prion protein: binding, inhibition of conversion, and species barriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

Drugs for malaria and psychosis may offer hope to people with CJD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

Molecular properties of complexes formed between the prion protein and synthetic peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

Histopathological and immunohistochemical evaluation of the first case of BSE in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

Epidemiological observations on spongiform encephalopathies in captive wild animals in the British Isles

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

Cell-free formation of protease-resistant prion protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

PrP polymorphisms associated with natural scrapie discovered by denaturing gradient gel electrophoresis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

Alpha-helical, but not beta-sheet, propensity of proline is determined by peptide environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

Solution structure of Syrian hamster prion protein rPrP(90-231).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

Temporary depletion of complement component C3 or genetic deficiency of C1q significantly delays onset of scrapie.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

Reversibility of scrapie inactivation is enhanced by copper

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

Fatal familial insomnia: clinical and pathologic study of five new cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

Designing peptide mimetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

The role of complement in the acquired immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

Copper stimulates endocytosis of the prion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

Antibodies inhibit prion propagation and clear cell cultures of prion infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

Mimicking dominant negative inhibition of prion replication through structure-based drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

Scrapie prions aggregate to form amyloid-like birefringent rods

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

NMR structure of the mouse prion protein domain PrP(121-231)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

Prion protein NMR structure and familial human spongiform encephalopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

Screening Congo Red and its analogues for their ability to prevent the formation of PrP-res in scrapie-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

Cell-lysate conversion of prion protein into its protease-resistant isoform suggests the participation of a cellular chaperone

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

Loss of cerebellar Purkinje cells in aged mice homozygous for a disrupted PrP gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

Immunization delays the onset of prion disease in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

Alzheimer's and prion disease as disorders of protein conformation: implications for the design of novel therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

Elimination of prions by branched polyamines and implications for therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

Effectiveness of anthracycline against experimental prion disease in Syrian hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

Tetracycline affects abnormal properties of synthetic PrP peptides and PrP(Sc) in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

A new variant of Creutzfeldt-Jakob disease in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

PrP deposition, microglial activation, and neuronal apoptosis in murine scrapie

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

Membrane topology influences N-glycosylation of the prion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

Naturally occurring scrapie-like spongiform encephalopathy in five domestic cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

Amphotericin B treatment dissociates in vivo replication of the scrapie agent from PrP accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

Quinacrine does not prolong survival in a murine Creutzfeldt-Jakob disease model

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

Monoclonal antibodies inhibit prion replication and delay the development of prion disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2003.00525.X

10.1046/J.1365-2885.2003.00525.X

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference